New diabetes pill shows promise in early human tests
NCT ID NCT00707954
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested an experimental drug called TA-7284 in 61 adults with type 2 diabetes. Participants took different doses (25 to 400 mg) or a placebo once daily for 15 days. The main goal was to check safety and how the drug moves through the body, with a secondary look at its effect on blood sugar and urine glucose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TA-7284 (an experimental oral diabetes drug)
What this could lead to
If successful, this could lead to a new daily pill to help control blood sugar in people with type 2 diabetes.
What could go wrong
This is a very early, small study (61 people) focused on safety and dosing, not on proving the drug works. Many drugs fail at this stage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
P-One Clinic
Hachiōji, Tokyo-to, Japan